Acquisition of OrganOx ~Expanding transplant opportunities for waiting patients globally and contributing to the development of transplant medicine~ Terumo Corporation Chief Executive Officer Hikaru Samejima August 27, 2025 Acquisition Overview | Target Company | OrganOx Limited | | --- | --- | | Acquisition Price | $1.5B（cash free / debt free basis） | | Transaction | Acquisition of 100% of OrganOx's outstanding shares in cash consideration | | Structure | | | Signing Date | August 23, 2025 | | | *Closing i ...